1.Management of severe hidradenitis suppurativa with biologic therapy and wide excision
Shi Yu Derek LIM ; Ee Cherk CHEONG ; Hazel H OON
Archives of Plastic Surgery 2019;46(3):272-276
Hidradenitis suppurativa (HS) is a chronic inflammatory follicular occlusive disease that involves the intertriginous areas. Treatment methods include conventional topical and systemic medication, radiotherapy, biologic agents, and surgical excision. Of late, there has been an increased focus on the use of biologic agents in patients with moderate to severe HS. Here, we present the case of a 46-year-old man with Hurley stage III HS for whom wide excision was ultimately curative, after aggressive medical therapy with the use of infliximab and adalimumab had succeeded in limiting the body surface area affected by the disease. This case demonstrates the effective treatment of severe HS with a combination of biologic therapy and surgery.
Adalimumab
;
Antibodies, Monoclonal
;
Biological Factors
;
Biological Therapy
;
Body Surface Area
;
Hidradenitis Suppurativa
;
Hidradenitis
;
Humans
;
Infliximab
;
Middle Aged
;
Radiotherapy
;
Tumor Necrosis Factor-alpha
2.The deep inferior epigastric perforator flap for breast reconstruction: Is this the ideal flap for Asian women?
Yan Lin YAP ; Jane LIM ; Catherine YAP-ASEDILLO ; Wei Chen ONG ; Ee Cherk CHEONG ; Shenthilkumar NAIDU ; Timothy SHIM ; Matthew YEO ; Margaret P G LEOW ; Thiam Chye LIM
Annals of the Academy of Medicine, Singapore 2010;39(9):680-686
INTRODUCTIONThis study aims to evaluate the outcome and safety of the deep inferior epigastric perforator (DIEP) flap for breast reconstruction in a group of Southeast Asian women treated in our unit and to identify risk factors for breast reconstruction using the DIEP flap in this population.
MATERIALS AND METHODSThis is a prospective study on 50 consecutive DIEP flap breast reconstructions by a single surgeon in an academic institution between July 1999 and July 2006. Data on patient demographics, diagnosis, procedure type, adjuvant and neoadjuvant treatments, risk factors and complications were prospectively collected and registered in a clinical database. Outcome variables include total flap loss, partial flap loss, fat necrosis and minor complications related to the donor site or flap. Known risk factors are analysed to determine if they affect outcome in terms of complication rate in this group of patients.
RESULTSTotal flap loss, partial flap loss and fat necrosis complication rates were 6%, 4% and 10%, respectively. Flap complication rates were comparable to those quoted by previous studies done worldwide. Obesity (BMI >27) is a statistically significant factor associated with development of DIEP flap complications in our population.
CONCLUSIONBreast reconstruction with DIEP flap is a safe and reliable method when used in Southeast Asian women, offering optimal results with less donor -site morbidity. Obesity increases the incidence of flap complication in this group of patients.
Abdomen ; surgery ; Adult ; Asian Continental Ancestry Group ; Breast ; surgery ; Databases, Factual ; Female ; Humans ; Mammaplasty ; adverse effects ; methods ; Microsurgery ; Middle Aged ; Multivariate Analysis ; Obesity ; Postoperative Complications ; Prospective Studies ; Rectus Abdominis ; surgery ; Risk Factors ; Surgical Flaps ; adverse effects ; Treatment Outcome ; Young Adult